Efficacy and Safety of Glofitamab Combined With GemOxin the Treatment of Refractory Diffuse Large B-Cell Lymphoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Dizal Pharmaceuticals
Genmab
Merck Sharp & Dohme LLC
Ohio State University Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
University of Wisconsin, Madison
H. Lee Moffitt Cancer Center and Research Institute
Massachusetts General Hospital
Swiss Cancer Institute
National Cancer Institute (NCI)
University of Washington
M.D. Anderson Cancer Center
Regeneron Pharmaceuticals
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
Mayo Clinic
University of Rochester
University Hospital Southampton NHS Foundation Trust
City of Hope Medical Center
University of Chicago
Hutchmed
Samsung Medical Center
Ruijin Hospital
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Shanghai Ming Ju Biotechnology Co., Ltd.
Genmab
Cothera Bioscience, Inc
Seoul National University Hospital
University of Southampton
Northwestern University
Shanghai Ming Ju Biotechnology Co., Ltd.
Nordic Lymphoma Group
Fudan University